Home › Funds › Caligan Partners LP › RVMD

Caligan Partners LP position in RVMD

REVOLUTION MEDICINES INC · Health Care

Caligan Partners LP reported holding 251,800 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$47.2M, representing 2.76% of its reported portfolio and ranking #8 among its reported holdings. Caligan Partners LP has disclosed RVMD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)251.80K sh
Reported value held$47.16M
Portfolio Weight2.76%
First reportedQ1 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Caligan Partners LP's RVMD position evolved

Caligan Partners LP first disclosed a stake in RVMD in Q1 2025 at 465,000 shares (US$16.4M). The position peaked in Q4 2025 at 1,283,900 shares, worth US$102.3M. Across 6 filings, Caligan Partners LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 251,800 shares valued at US$47.2M — an increase of 22,900 shares quarter over quarter.. Notable position changes include a 37% increase in Q2 2025 (shares rose 27% over the following quarter), a 67% increase in Q3 2025 (shares rose 71% over the following quarter), a 82% trim in Q1 2026 (shares rose 93% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 465.00K $16.44M New
Q2 2025 636.84K $23.43M Add
Q3 2025 1.06M $49.70M Add
Q4 2025 1.28M $102.26M Add
Q1 2026 228.90K $22.26M Reduce
Q2 2026 251.80K $47.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 61 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has Caligan Partners LP held RVMD?

Caligan Partners LP has disclosed RVMD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Caligan Partners LP's current position in RVMD?

As of Q2 2026, Caligan Partners LP holds 251.80K shares of RVMD (REVOLUTION MEDICINES INC), valued at $47.16M, representing 2.76% of its reported portfolio and ranking #8.

Has Caligan Partners LP been buying or selling RVMD?

In the latest 13F filing (Q2 2026), Caligan Partners LP increased its position in RVMD. The position peaked in Q4 2025 at 1.28M shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.